Search…

Innovative drug concept rebounds from bottoming out, Haofan Biology rises nearly 10%

10/04/2026

The concept of innovative drugs hit a bottom and rebounded in the intraday trading, Hao Fan Biological rose by nearly 10%, Ha Sanlian touched the daily limit, Duorui Pharmaceuticals, Zhixiang Jintai, Haisike, Borui Pharmaceuticals, Medice etc. followed the rise.

Latest

2 m ago

Ceasefire agreement boost Asian stock markets, potentially bringing the best single-week performance since 2022.

2 m ago

According to Mei AI News, Huayuan Securities released a research report on April 10, giving Wumei Biology (603983.SH) a "buy" rating. The main reasons for the rating include: 1) The revenue of eye care and skincare products is growing well; 2) The company's net profit margin has slightly decreased, while the sales expense ratio continues to rise. (Daily Economic News)

3 m ago

According to the AI Fast News, Dongwu Securities issued a research report on April 10th giving a "buy" rating to Barbican Food (605338.SH). The rating reasons mainly include: 1) The growth in store numbers is impressive, and the revenue per store is recovering positively; 2) Profit margins are in line with expectations, with a steady increase in non-net profit margins; 3) Positive feedback on the Xiaolongbao store type, focusing on the marginal catalysis of the peak season for opening new stores. (Daily Economic News)

4 m ago

According to data from the Malaysian Palm Oil Board, Malaysia's crude palm oil production in March was 1.38 million tons, an increase of 7.21% from February.

5 m ago

Alibaba's ATH department stated that HappyHorse is a model developed by Alibaba's ATH innovation business unit and is currently in the internal testing phase. The API will be opened soon. The ATH innovation business unit has launched a new exploration plan for a new interactive way in the AI era, and HappyHorse is part of this exploration direction. More products will be launched gradually. (YiCai).

See all latest